EB

Emily Bodnar

#91 out of 1960 analysts
HC Wainwright & Co.
Automatically Tracked
Tracking: 0 Updated: 29 minutes ago

Analyst ratings are aggregated from multiple third-party sources and may be inaccurate, incomplete, or outdated. All ratings remain the sole responsibility of their original providers. Rankings are based on the 3-year performance of a simulated $100,000 account trading on analyst ratings data.

Gain and growth charts are calculated per selected timeframe:
83.16%
Gain -0.82%
Monthly
1.16%
Yearly
14.86%
Drawdown
13.81%
$811.65M
Equity
Holdings
$631.28M
Cash
$180.37M
Investment
$548.93M
$368.46M
Profit -$6.73M
Realized
$286.11M
Unrealized
$82.35M
Dividends
$0
$180.37M
Cash
Deposits
$443.19M
Withdrawals
$0
Commissions
$0

Goals

Avg. 0% completed goals
Today
Compared To Yesterday
Gain
-0.82%
Profit
-$6.73M
Win %
65%
This Week
Compared To Last Week
Gain
1.95%
Profit
$15.21M
Win %
65%
This Month
Compared to last month
Gain
7.74%
Profit
$57.01M
Win %
65%
This Year
Compared to last year
Gain
27.24%
Profit
$169.87M
Win %
60%
BriaCell Therapeutics Corp. logo
BCTX BriaCell Therapeutics Corp.
+4.75%
-$95,571.46
Agios Pharmaceuticals Inc. logo
AGIO Agios Pharmaceuticals Inc.
+0.96%
+$503,892.58
Autolus Therapeutics plc American Depositary Receipt logo
AUTL Autolus Therapeutics plc American Depositary Receipt
+0.33%
+$123,958.69
AnaptysBio Inc. logo
ANAB AnaptysBio Inc.
+0.21%
+$157,876.27
Purple Biotech Ltd. logo
PPBT Purple Biotech Ltd.
0%
$0
First Tracks Biotherapeutics, Inc. logo
TRAX First Tracks Biotherapeutics, Inc.
-5.52%
-$905,605.54
MiNK Therapeutics, Inc. logo
INKT MiNK Therapeutics, Inc.
-5.3%
-$2.07M
Atossa Therapeutics Inc logo
ATOS Atossa Therapeutics Inc
-4.51%
-$1.04M
Artiva Biotherapeutics Inc. logo
ARTV Artiva Biotherapeutics Inc.
-4.08%
-$3.2M
Agenus Inc. logo
AGEN Agenus Inc.
-4%
+$1,941.56
Olema Pharmaceuticals Inc. logo
OLMA Olema Pharmaceuticals Inc.
-3.54%
-$506,397.66
Transcode Therapeutics Inc. logo
RNAZ Transcode Therapeutics Inc.
-2.01%
+$481,382.42
NextCure, Inc. logo
NXTC NextCure, Inc.
-1.51%
+$372,713.61
Sab Biotherapeutics Inc. logo
SABS Sab Biotherapeutics Inc.
-1.28%
-$506,397.66
TG Therapeutics, Inc. logo
TGTX TG Therapeutics, Inc.
-0.08%
-$52,176.29
Loading...

Dividends

Dividend Analysis

Yearly
$
Trades
2204
Longs Won
963/2077 46%
Profit Factor
3.08
Profitability
Shorts Won
89/127 70%
Standard Deviation
$1.7M
Average Win
$518,622.75
Best Trade
(Oct 09) $39.07M
Sharpe Ratio
-999.4
Average Loss
-$153,760.93
Worst Trade
(Jun 16) -$12.76M
Z-Score
-11.54 (99.94%)
Commissions
$0
Avg. Trade Length
2m 2w 2d
Expectancy
$167,177.2
Loss Size 100% 90% 80% 70% 60% 50% 40% 30% 20% 10%
Probability of Loss <0.01% <0.01% <0.01% <0.01% <0.01% <0.01% <0.01% <0.01% <0.01% 0.01%
Consecutive Losing Trades 5,291 4,762 4,233 3,704 3,175 2,646 2,116 1,587 1,058 529
Hover over the desired column for a detailed explanation.

Returns

Overall, Monthly
No Data
Option values are updated at end of day.
No Data
No Data
Option values are updated at end of day.
No Data
No Data
No Data
No Data
Account USV